Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.506ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.506ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.506ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.506NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.6.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.6.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.6.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.438.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.438.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.188ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.188ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.188ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.188NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.501ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15413.7France
B.1.501ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.501ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.501NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.226ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.226ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.226ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.226NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.546ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.546ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.546ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.546NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.194ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.194ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.194ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.194NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.429.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used